ShangPharma Corp. (SHP) Misses Q2 EPS by 9c; Revises FY12 Sales Outlook
Tweet
Share
E-mailGet Alerts SHP Hot Sheet
Join SI Premium – FREE
ShangPharma Corp. (NYSE: SHP) reported Q2 EPS of $0.11, $0.09 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $31.8 million versus the consensus estimate of $32.84 million.
ShangPharma Corp. sees FY2012 revenue of $131.7-136.2 million, versus the consensus of $134.19 million.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
ShangPharma Corp. sees FY2012 revenue of $131.7-136.2 million, versus the consensus of $134.19 million.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Comerica (CMA) PT Raised to $54 at Piper Sandler
- Oilfield firm SLB's profit rises on international drilling demand
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
